Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2025
The development of an international partnership for cranial neurosurgery in The Gambia.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gupta Saksham, Manneh Ebrima K, Bah Momodou G, Kangakan Sabina, AlKhateeb Anwar, Sadibou Sheikh, Sánchez Camejo, Chrenek Ryan, Gal Zsombor T, Jallow Cherno S, Aziz-Sultan Mohammad A, Olatunde Kingsley Isaac, Daniel Ajibola, Bah Aji Jahou, Janneh Lamin, Malik Hinna, Bittaye Mustapha, Smith Timothy R, Jabang John N
Аннотация
BACKGROUND: There is a considerable burden of pituitary and other skull base diseases in low-and-middle-income countries that often go unaddressed. In this study, we describe the development of an institutional partnership between Mass General Brigham (MGB) and the Edward Francis Small Teaching Hospital (EFSTH; The Gambia) to develop the capacity to perform complex cranial neurosurgery with a focus on pituitary surgery.
METHODS: This is a case series of 5 operations performed at EFSTH from September 17-19, 2024.
RESULTS: 5 operations were performed, including 3 for pituitary macroadenoma, 1 for giant falcine meningioma, and 1 for postcentral gyrus tuberculoma. Operative times ranged from 3 to 9 h and estimated blood loss ranged from 200 to 800 cc. There were no intraoperative complications, though one patient suffered a delayed venous infarction that caused transient weakness and inability to ambulate. All patients were discharged home, and all patients' preoperative symptoms improved by final follow-up. The crude long-term cost efficacy of performing pituitary surgery was approximated to be $21 US dollars (USD) in productivity gained for every $1 spent.
CONCLUSIONS: We describe the early development of a new global neurosurgery partnership between EFSTH and MGB, which includes the country's first pituitary operation.
METHODS: This is a case series of 5 operations performed at EFSTH from September 17-19, 2024.
RESULTS: 5 operations were performed, including 3 for pituitary macroadenoma, 1 for giant falcine meningioma, and 1 for postcentral gyrus tuberculoma. Operative times ranged from 3 to 9 h and estimated blood loss ranged from 200 to 800 cc. There were no intraoperative complications, though one patient suffered a delayed venous infarction that caused transient weakness and inability to ambulate. All patients were discharged home, and all patients' preoperative symptoms improved by final follow-up. The crude long-term cost efficacy of performing pituitary surgery was approximated to be $21 US dollars (USD) in productivity gained for every $1 spent.
CONCLUSIONS: We describe the early development of a new global neurosurgery partnership between EFSTH and MGB, which includes the country's first pituitary operation.